nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—CYP1A2—Methimazole—Graves' disease	0.594	0.656	CbGbCtD
SIMEPREVIR—CYP3A4—Methimazole—Graves' disease	0.311	0.344	CbGbCtD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-E—Graves' disease	0.0187	0.197	CbGpPWpGaD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-B—Graves' disease	0.0133	0.14	CbGpPWpGaD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-A—Graves' disease	0.0123	0.13	CbGpPWpGaD
SIMEPREVIR—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.00449	0.0472	CbGpPWpGaD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-E—Graves' disease	0.00382	0.0402	CbGpPWpGaD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-B—Graves' disease	0.00272	0.0287	CbGpPWpGaD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-A—Graves' disease	0.00252	0.0266	CbGpPWpGaD
SIMEPREVIR—CTSS—MHC class II antigen presentation—HLA-DQB1—Graves' disease	0.0025	0.0263	CbGpPWpGaD
SIMEPREVIR—CTSS—MHC class II antigen presentation—HLA-DRB1—Graves' disease	0.0019	0.02	CbGpPWpGaD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-E—Graves' disease	0.00153	0.0161	CbGpPWpGaD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—Graves' disease	0.00109	0.0114	CbGpPWpGaD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-A—Graves' disease	0.00101	0.0106	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—IFIH1—Graves' disease	0.001	0.0105	CbGpPWpGaD
SIMEPREVIR—CTSS—Extracellular matrix organization—ICAM1—Graves' disease	0.000852	0.00896	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—HLA-E—Graves' disease	0.000787	0.00828	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-E—Graves' disease	0.000756	0.00795	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD40—Graves' disease	0.000739	0.00777	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CTLA4—Graves' disease	0.000728	0.00766	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-E—Graves' disease	0.000637	0.0067	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CD40—Graves' disease	0.000622	0.00655	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CTLA4—Graves' disease	0.000613	0.00645	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-DQB1—Graves' disease	0.0006	0.00631	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000597	0.00628	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IFIH1—Graves' disease	0.000583	0.00613	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000564	0.00593	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—HLA-B—Graves' disease	0.000561	0.0059	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD8A—Graves' disease	0.00056	0.00589	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-B—Graves' disease	0.000539	0.00567	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-DQB1—Graves' disease	0.000505	0.00531	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-A—Graves' disease	0.000499	0.00525	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000499	0.00525	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—ICAM1—Graves' disease	0.000486	0.00511	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-E—Graves' disease	0.000458	0.00482	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000456	0.0048	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000454	0.00478	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-B—Graves' disease	0.000454	0.00477	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD40—Graves' disease	0.000448	0.00471	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—FASLG—Graves' disease	0.000443	0.00466	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CTLA4—Graves' disease	0.000442	0.00465	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—ICAM1—Graves' disease	0.000438	0.0046	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—FAS—Graves' disease	0.000428	0.0045	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL2RA—Graves' disease	0.000425	0.00447	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-A—Graves' disease	0.00042	0.00442	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000405	0.00426	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000386	0.00406	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-DRB1—Graves' disease	0.000384	0.00404	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IFNG—Graves' disease	0.00037	0.00389	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-DQB1—Graves' disease	0.000364	0.00383	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000345	0.00363	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD8A—Graves' disease	0.00034	0.00357	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—CD4—Graves' disease	0.000335	0.00352	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL1B—Graves' disease	0.00033	0.00347	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-B—Graves' disease	0.000327	0.00344	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000322	0.00339	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD4—Graves' disease	0.000322	0.00338	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000308	0.00324	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL2RA—Graves' disease	0.000306	0.00322	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-A—Graves' disease	0.000303	0.00318	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.000294	0.00309	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.000294	0.00309	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000285	0.003	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IFNG—Graves' disease	0.00028	0.00295	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-DRB1—Graves' disease	0.000277	0.00291	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ICAM1—Graves' disease	0.000265	0.00279	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.000262	0.00275	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—GC—Graves' disease	0.000251	0.00264	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL1B—Graves' disease	0.00025	0.00263	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00025	0.00263	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TNF—Graves' disease	0.000239	0.00252	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000225	0.00237	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	0.000223	0.00235	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	0.000223	0.00235	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000219	0.0023	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000213	0.00224	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000211	0.00222	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IFNG—Graves' disease	0.000202	0.00212	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD4—Graves' disease	0.000195	0.00205	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—B3GNT2—Graves' disease	0.00019	0.002	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—TNF—Graves' disease	0.00019	0.002	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—TNF—Graves' disease	0.000182	0.00191	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL1B—Graves' disease	0.00018	0.00189	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—GC—Graves' disease	0.000144	0.00151	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—GC—Graves' disease	0.000126	0.00132	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—IL2RA—Graves' disease	0.00011	0.00116	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—B3GNT2—Graves' disease	0.000109	0.00114	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—GC—Graves' disease	0.0001	0.00106	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—B3GNT2—Graves' disease	9.53e-05	0.001	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	8.96e-05	0.000942	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—GC—Graves' disease	7.75e-05	0.000815	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—B3GNT2—Graves' disease	7.61e-05	0.0008	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—B3GNT2—Graves' disease	5.87e-05	0.000618	CbGpPWpGaD
